Abstract

Aim Scutellariae Radix (SR) and Coptidis Rhizoma (CR) have often been combined to cure type 2 diabetes mellitus (T2DM) in the clinical practice for over thousands of years, but their compatibility mechanism is not clear. Mitogen-activated protein kinase (MAPK) signaling pathway has been suggested to play a critical role during the process of inflammation, insulin resistance, and T2DM. This study was designed to investigate their compatibility effects on T2DM rats and explore the underlying mechanisms by analyzing the metabolic profiling and MAPK/PI3K/Akt signaling pathway. Methods The compatibility effects of SR and CR were evaluated with T2DM rats induced by a high-fat diet (HFD) along with a low dose of streptozocin (STZ). Ultra performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF/MS) was performed to discover potential biomarkers. The levels of pro-inflammatory cytokines; biochemical indexes in serum, and the activities of key enzymes related to glycometabolism in liver were assessed by ELISA kits. qPCR was applied to examine mRNA levels of key targets in MAPK and insulin signaling pathways. Protein expressions of p65; p-p65; phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K); phosphorylated-PI3K (p-PI3K); protein kinase B (Akt); phosphorylated Akt (p-Akt) and glucose transporter 2 (Glut2) in liver were investigated by Western blot analysis. Results Remarkably, hyperglycaemia, dyslipidemia, inflammation, and insulin resistance in T2DM were ameliorated after oral administration of SR and CR, particularly their combined extracts. The effects of SR, CR, low dose of combined extracts (LSC) and high dose of combined extracts (HSC) on pro-inflammatory cytokine transcription in T2DM rats showed that the MAPK pathway might account for the phenomenon with down-regulation of MAPK (P38 mitogen-activated protein kinases (P38), extracellular regulated protein kinases (ERK), and c-Jun N-terminal kinase (JNK)) mRNA, and protein reduction in p-P65. While mRNA levels of key targets such as insulin receptor substrate 1 (IRS1), PI3K, Akt2, and Glut2 in the insulin signaling pathway were notably up-modulated, phosphorylations of PI3K, Akt, and expression of Glut2 were markedly enhanced. Moreover, the increased activities of phosphoenolpyruvate carboxykinase (PEPCK), fructose-1,6-bisphosphatase (FBPase), glucose 6-phosphatase (G6Pase), and glycogen phosphorylase (GP) were highly reduced and the decreased activities of glucokinase (GK), phosphofructokinase (PFK), pyruvate kinase (PK), and glycogen synthase (GS) in liver were notably increased after treatment. Further investigation indicated that the metabolic profiles of plasma and urine were clearly improved in T2DM rats. Fourteen potential biomarkers (nine in plasma and five in urine) were identified. After intervention, these biomarkers returned to normal level to some extent. Conclusion The results showed that SR, CR, and combined extract groups were normalized. The effects of combined extracts were more remarkable than single herb treatment. Additionally, this study also showed that the metabonomics method is a promising tool to unravel how traditional Chinese medicines work.

Highlights

  • Type 2 diabetes mellitus (T2DM), characterized by increased blood glucose level resulting from disturbances of insulin secretion, insulin action or both, is a complex disorder influenced by both lifestyle and genetic factors

  • Current diabetes treatments have exhibited some success in lowering blood glucose levels, their effects are not always sustained and their use may be associated with undesirable side effects such as hypoglycemia [6], gastrointestinal discomfort [7], etc

  • Previous studies suggested that macrophage-specific TGR5 signaling in kupffer cells protected liver from inflammation and insulin resistance.An increase of cholic acid and deoxycholic acid was found, while glycocholic acid was decreased in T2DM rats

Read more

Summary

Introduction

Type 2 diabetes mellitus (T2DM), characterized by increased blood glucose level resulting from disturbances of insulin secretion, insulin action or both, is a complex disorder influenced by both lifestyle and genetic factors. Drugs clinically used to treat T2DM include insulin sensitizers, insulin secreting drugs, insulin, etc. Current diabetes treatments have exhibited some success in lowering blood glucose levels, their effects are not always sustained and their use may be associated with undesirable side effects such as hypoglycemia [6], gastrointestinal discomfort [7], etc. It is urgent to discover new and effective drugs with fewer side effects to cure T2DM. Successful therapies for T2DM have been available from TCM practitioners. Many researchers have focused on developing potent therapies and drugs from Chinese herbs with fewer side effects on T2DM patients

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call